Pierce Kristen 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Pierce Kristen
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-30+154,841→ 154,841 totalExercise: $0.45Exp: 2035-05-29→ Common Stock (154,841 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest in equal monthly installments through June 4, 2027.